Company’s rotary screen printers are producing millions of COVID-19 rapid tests.
David Savastano, Editor12.08.20
The ability to print sensors has many benefits, including lower cost and faster production output. In particular, screenprinting is prominently used, with one major example being glucose test strips for diabetes patients. Now, as the world battles COVID-19, pharmaceutical companies around the world are looking to meet the need for millions of test strips.
SPGPrints B.V. is among the printing equipment specialists who have adapted its experience in rotary screen printing for biosensors to working on COVID-19 cures. Due to the close collaboration between SPGPrints and its client, millions of test strips are expected to be produced in the upcoming months.
Hank Guitjens, commercial manager label & industrial printing for SPGPrints B.V., noted that SPGPrints started to supply its rotary screen solutions to pharmaceutical companies in the biosensor industry about 10 years ago, and these are being successfully used to produce COVID-19 tests.
Guitjens not
Continue reading this story and get 24/7 access to Covering the Printing Inks, Coatings and Allied Industries - Ink World for FREE
Ink World magazine has tracked the growth of the ink industry and its allied industries through years of changes, technology, evolution, consolidation and market development. No other magazine has been around for as long or covered as much of the global printing ink business. This website is dedicated to providing in-depth industry coverage and late-breaking news.
FREE SUBSCRIPTION
Already a subscriber? Login